Therapeutic Uses
There is some evidence that vitamin A supplements reduce deaths from measles and other infectious illnesses among children in developing countries,
3,39
presumably because they correct a deficiency in the children's diets. This doesn't mean that vitamin A supplements above and beyond the basic nutritional requirement are a useful treatment for measles or any other childhood disease.
Vitamin A might improve blood sugar control in people with
diabetes. Unfortunately, people with diabetes may also be especially vulnerable to liver damage from excessive amounts of vitamin A (see
Safety Issues
). Therefore, if you have diabetes, you should take vitamin A only on the advice of a physician.
Vitamin A has shown some potential for preventing one type of skin cancer (squamous cell cancer).
41,42
However, in these studies, doses above the standard safe upper limits have been used. With proper monitoring, this may be safe, but we do not recommend trying it without physician supervision. High-dose vitamin A has been tried for a variety of other skin diseases, including
acne
,
psoriasis
,
rosacea
,
seborrhea
, and
eczema
,
21-24
as well as menorrhagia (heavy menstruation)
4
and
retinitis pigmentosa
(a chronic disease of the eyes).
43-44
However, the benefits seen have been modest at best, and again the recommended dosages of vitamin A are so high as to raise concerns about toxic risk.
Vitamin A might be beneficial for people with HIV; however, results of studies have been contradictory, and some evidence even suggests that vitamin A supplements might increase transmission of the disease from a pregnant mother to her newborn.
45
Topical vitamin A may be helpful for treatment of aging skin. One double-blind, placebo-controlled study found that a 0.4% vitamin A lotion applied three times a week significantly reduced the number of “fine” wrinkles in seniors.
46
Benefits were also seen in terms of some biochemical measures of skin health.
On the basis of very weak evidence, too weak to be relied upon at all, vitamin A has been proposed as a treatment for a wide variety of other conditions, including Down's syndrome,
ear infections
,
eating disorders
,
glaucoma
,
gout
, impaired
night vision
,
kidney stones
,
lupus
,
multiple sclerosis
,
ulcerative colitis
, and
ulcers.
One study suggests that vitamin A is
not
effective for
Crohn's disease.
12
References
1
Combs G.
The Vitamins.
2nd ed. New York, NY: Academic Press; 1998:5-6.
2
West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption.
Gut.
1975;16:93-98.
3
Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis.
BMJ.
1993;306:366-370.
4
Lithgow DM, Politzer WM. Vitamin A in the treatment of menorrhagia.
S Afr Med J.
1977;51:191-193.
5
Semba RD, Graham NM, Caiaffa WT, et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection.
Arch Intern Med.
1993;153:2149-2154.
6
Bianchi-Santamaria A, Fedeli S, Santamaria L. Short communication: possible activity of beta-carotene in patients with the AIDS related complex. A pilot study.
Med Oncol Tumor Pharmacother.
1992;9:151-153.
7
Alexander M, Newmark H, Miller RG. Oral beta-carotene can increase the number of OKT4+ cells in human blood.
Immunol Lett.
1985;9:221-224.
8
Fryburg DA, Mark RJ, Griffith BP, et al. The effect of supplemental beta-carotene in immunologic indices in patients with AIDS: a pilot study.
Yale J Biol Med.
1995;68:19-23.
9
Coodley GO, Nelson HD, Loveless MO, et al. Beta-carotene in HIV infection.
J Acquir Immune Defic Syndr Hum Retrovirol.
1993;6:272-276.
10
Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation.
AIDS.
1996;10:967-973.
11
Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study.
Clin Infect Dis.
1996;23:654-656.
12
Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy in patient's with Crohn's disease.
Gastroenterology.
1985;88:512-514.
13
Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis.
BMJ.
1993;306:366-370.
14
Bresee JS, Fischer M, Dowell SF, et al. Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States.
Pediatr Infect Dis J.
1996;15:777-782.
15
Neuzil KM, Gruber WC, Chytil F, et al. Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections.
Antimicrob Agents Chemother.
1995;39:1191-1193.
16
Martinoli L, Di Felice M, Seghieri G, et al. Plasma retinol and alpha-tocopherol concentrations in insulin-dependent diabetes mellitus: their relationship to microvascular complications.
Int J Vitam Nutr Res.
1993;63:87-92.
17
Singh RB, Niaz MA, Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: a hospital-based case-control study.
J Nutr Environ Med.
1995;5:235-242.
18
Basualdo CG, Wein EE, Basu TK. Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus.
J Am Coll Nutr.
1997;16:39-45.
19
Straub RH, Rokitzki L, Schumacher T, et al. No evidence of deficiency of vitamins A, E, beta-carotene, B1, B2, B6, B12 and folate in neuropathic type II diabetic women.
Int J Vitam Nutr Res.
1993;63:239-240.
20
Facchini F, Coulston AM, Reaven GM. Relation between dietary vitamin intake and resistance to insulin-mediated glucose disposal in healthy volunteers.
Am J Clin Nutr.
1996;63:946-949.
21
Stoesser AV, Nelson LS. Synthetic vitamin A in the treatment of eczema in children.
Ann Allergy.
1952;10:703-704.
22
Kligman AM, Mills OH Jr, Leyden JJ, et al. Oral vitamin A in acne vulgaris. Preliminary report.
Int J Dermatol.
1981;20:278-285.
23
Marrakchi S, Kim I, Delaporte E, et al. Vitamin A and E blood levels in erythrodermic and pustular psoriasis associated with chronic alcoholism.
Acta Derm Venereol.
1994;74:298-301.
24
Brenner S, Horwitz C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators: essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C; selenium; zinc; iron.
World Rev Nutr Diet.
1988;55:165-182.
25
Lithgow DM, Politzer WM. Vitamin A in the treatment of menorrhagia.
S Afr Med J.
1977;51:191-193.
26
Coodley GO, Nelson HD, Loveless MO, et al. Beta-carotene in HIV infection.
J Acquir Immune Defic Syndr Hum Retrovirol.
1993;6:272-276.
27
Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation.
AIDS.
1996;10:967-973.
28
Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study [letters].
Clin Infect Dis.
1996;23:654-656.
29
Tang AM, Graham NHM, Kirby AJ, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men.
Am J Epidemiol.
1993;138:937-951.
30
Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection.
Am J Epidemiol.
1996;143:1244-1256.
31
Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania.
J Acquir Immune Defic Syndr Hum Retrovirol.
2000;23:246-254.
32
Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group.
AIDS.
1999;13:1517-1524.
33
Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy in patient's with Crohn's disease.
Gastroenterology.
1985;88:512-514.
34
Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity.
Am J Clin Nutr.
1999;69:1071-1085.
35
Melhus H, Michaelsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture.
Ann Intern Med.
1998;129:770-778.
36
Nau H, Tzimas G, Mondry M, et al. Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy.
Life Sci.
1995;57:53-60.
37
Harris JE. Interaction of dietary factors with oral anticoagulants: review and applications.
J Am Diet Assoc.
1995;95:580-584.
38
Institute of Medicine.
Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc.
Washington, DC: National Academy Press; 2001.
39
D'Souza RM, D'Souza R. Vitamin A for the treatment of children with measles—a systematic review.
J Trop Pediatr.
2002;48:323-327.
40
Michaelsson K, Lithell H, Vessby B, et al. Serum retinol levels and the risk of fracture.
N Engl J Med.
2003;348:287-294.
41
Moon TE, Levine N, Cartmel B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Cancer Epidemiol Biomarkers Prev.
1997;6:949-956.
42
Alberts D, Ranger-Moore J, Einspahr J, et al. Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin.
Clin Cancer Res.
2004;10:1875-1880.
43
Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
Arch Ophthalmol.
1993;111:761-72
44
Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Arch Ophthalmol.
2004;122:1297-1305
45
Mehta S, Fawzi W. Effects of Vitamins, Including Vitamin A, on HIV/AIDS Patients.
Vitam Horm.
2007;75:355-383.
46
Kafi R, Kwak HS, Schumacher WE, et al. Improvement of naturally aged skin with vitamin a (retinol).
Arch Dermatol.
2007;143:606-612.
47
Chen H, Zhuo Q, Wang J, Wu T. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age.
Cochrane Database Syst Rev.
2011;(1):CD006090.